Hercules Capital, Inc. HTGX 深 滬
等待開盤 09-27 09:30:00 美东时间
25.00
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 25.00
- 總市值 11.28亿
- 52周最高 24.8488
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 23.3779
- 委 比 0.00%
- 總股本 4511.60万
- 歷史最高 24.8488
- 量 比 0
- 振 幅 0.00%
- 歷史最低 16.7554
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多uniQure Secures $175 Million Loan Amendment
The latest announcement is out from uniQure ( ($QURE) ). On September 22, 2025,...
09-25 16:20
What's Going On With UniQure Stock Wednesday?
UniQure N.V. (NASDAQ:QURE) shares are trading higher Wednesday after the company announced positive topline results from Phase I/II study of AMT-130 in patients with Huntington's Disease.
09-25 01:57
美股异动 | 亨廷顿病关键研究取得积极进展 uniQure(QURE.US)暴涨超186%
周三，uniQure(QURE.US)暴涨超186%，创四年新高，报39.11美元。
09-24 22:29
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial
UniQure's AMT-130 gene therapy slowed Huntington's disease progression in a Phase 1/2 trial, supported by new $175 million financing for launch readiness.
09-24 22:23
uniQure Refinances $50M Debt And Gains Access To Additional $125M Non-Dilutive Funding From Hercules Capital
Term of current $50 million debt outstanding extended from January 2027 to October 2030Additional $100 million available subject to regulatory and financial milestonesAdditional $25 million available subject to Hercules'
09-24 19:12
Senseonics Holdings Memorandum Of Understanding To Transition All Commercialization And Distribution Of Eversense 365 And Future Products From Ascensia Diabetes Care; Non-dilutive Debt Facility Expanded Up To $100M With Hercules Capital To Fund Commercial Organization
CGM commercial operations to transition from Ascensia Diabetes Care to SenseonicsBrian Hansen to be appointed Chief Commercial OfficerNon-dilutive debt facility expanded up to $100 million with Hercules Capital to fund
09-04 05:22
Heron Therapeutics announces capital restructuring to support growth
Heron Therapeutics (NASDAQ:HRTX) Friday reported the completion of a comprehensive capital restructuring designed to enhance the company's financial flexibility, reduce total debt, and support long-te...
08-08 20:41
JMP Securities Maintains Market Outperform on Hercules Capital, Raises Price Target to $24
JMP Securities analyst Devin Ryan maintains Hercules Capital (NYSE:HTGC) with a Market Outperform and raises the price target from $22 to $24.
08-04 19:58
Hercules Capital Announces Q2 2025 Cash Distribution
Hercules Capital ( ($HTGC) ) has provided an announcement. On July 29, 2025, He...
08-01 05:18
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
